WorldQuant Millennium Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
WorldQuant Millennium Advisors's GILD Position: Q1 2026 in Review
WorldQuant Millennium Advisors increased its Gilead Sciences (GILD) stake by 109% in Q1 2026, buying an estimated $31.3M and bringing the position to 429,035 shares worth $59.8M. The position accounts for 0.23% of the portfolio, ranked #114.
WorldQuant Millennium Advisors first reported a position in GILD in Q1 2019 and has held it in 27 quarters since. The position peaked at $136M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- WorldQuant Millennium Advisors held 429,035 shares of Gilead Sciences worth $59.8M as of Q1 2026.
- WorldQuant Millennium Advisors bought 223,470 Gilead Sciences shares in Q1 2026, an estimated $31.3M.
- Gilead Sciences made up 0.23% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #114 holding.
- WorldQuant Millennium Advisors first reported a position in Gilead Sciences in Q1 2019 and has held it in 27 quarters since.
- WorldQuant Millennium Advisors's Gilead Sciences position peaked at $136M in Q3 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.